• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过调控腺相关病毒载体介导的胶质细胞源性神经营养因子(GDNF)基因转移至耳蜗来预防氨基糖苷类药物引起的耳毒性。

Protection against aminoglycoside-induced ototoxicity by regulated AAV vector-mediated GDNF gene transfer into the cochlea.

作者信息

Liu Yuhe, Okada Takashi, Shimazaki Kuniko, Sheykholeslami Kianoush, Nomoto Tatsuya, Muramatsu Shin-Ichi, Mizukami Hiroaki, Kume Akihiro, Xiao Shuifang, Ichimura Keiichi, Ozawa Keiya

机构信息

Division of Genetic Therapeutics, Jichi Medical University, Tochigi, Japan.

出版信息

Mol Ther. 2008 Mar;16(3):474-80. doi: 10.1038/sj.mt.6300379. Epub 2008 Jan 8.

DOI:10.1038/sj.mt.6300379
PMID:18180779
Abstract

Since standard aminoglycoside treatment progressively causes hearing disturbance with hair cell degeneration, systemic use of the drugs is limited. Adeno-associated virus (AAV)-based vectors have been of great interest because they mediate stable transgene expression in a variety of postmitotic cells with minimal toxicity. In this study, we investigated the effects of regulated AAV1-mediated glial cell line-derived neurotrophic factor (GDNF) expression in the cochlea on aminoglycoside-induced damage. AAV1-based vectors encoding GDNF or vectors encoding GDNF with an rtTA2s-S2 Tet-on regulation system were directly microinjected into the rat cochleae through the round window at 5 x 10(10) genome copies/body. Seven days after the virus injection, a dose of 333 mg/kg of kanamycin was subcutaneously given twice daily for 12 consecutive days. GDNF expression in the cochlea was confirmed and successfully modulated by the Tet-on system. Monitoring of the auditory brain stem response revealed an improvement of cochlear function after GDNF transduction over the frequencies tested. Damaged spiral ganglion cells and hair cells were significantly reduced by GDNF expression. Our results suggest that AAV1-mediated expression of GDNF using a regulated expression system in the cochlea is a promising strategy to protect the cochlea from aminoglycoside-induced damage.

摘要

由于标准的氨基糖苷类药物治疗会随着毛细胞变性逐渐导致听力障碍,因此该药物的全身应用受到限制。基于腺相关病毒(AAV)的载体备受关注,因为它们能在多种有丝分裂后细胞中介导稳定的转基因表达,且毒性极小。在本研究中,我们调查了耳蜗中受调控的AAV1介导的胶质细胞源性神经营养因子(GDNF)表达对氨基糖苷类药物诱导损伤的影响。将编码GDNF的基于AAV1的载体或编码带有rtTA2s - S2 Tet - on调控系统的GDNF的载体以5×10(10)基因组拷贝/体的剂量通过圆窗直接显微注射到大鼠耳蜗中。病毒注射7天后,每天皮下注射两次333 mg/kg的卡那霉素,连续注射12天。通过Tet - on系统证实并成功调节了耳蜗中的GDNF表达。对听觉脑干反应的监测显示,在测试频率范围内,GDNF转导后耳蜗功能得到改善。GDNF表达显著减少了受损的螺旋神经节细胞和毛细胞。我们的结果表明,在耳蜗中使用受调控表达系统由AAV1介导GDNF表达是一种保护耳蜗免受氨基糖苷类药物诱导损伤的有前景的策略。

相似文献

1
Protection against aminoglycoside-induced ototoxicity by regulated AAV vector-mediated GDNF gene transfer into the cochlea.通过调控腺相关病毒载体介导的胶质细胞源性神经营养因子(GDNF)基因转移至耳蜗来预防氨基糖苷类药物引起的耳毒性。
Mol Ther. 2008 Mar;16(3):474-80. doi: 10.1038/sj.mt.6300379. Epub 2008 Jan 8.
2
Protection Against Aminoglycoside-induced Ototoxicity by Regulated AAV Vector-mediated GDNF Gene Transfer Into the Cochlea.通过调控腺相关病毒载体介导的胶质细胞源性神经营养因子基因转移至耳蜗来预防氨基糖苷类药物诱导的耳毒性
Mol Ther. 2008 Mar;16(3):474-480. doi: 10.1038/sj.mt.6300379. Epub 2016 Dec 8.
3
Virally Mediated Overexpression of Glial-Derived Neurotrophic Factor Elicits Age- and Dose-Dependent Neuronal Toxicity and Hearing Loss.病毒介导的胶质源性神经营养因子过表达引起年龄和剂量依赖性神经元毒性和听力损失。
Hum Gene Ther. 2019 Jan;30(1):88-105. doi: 10.1089/hum.2018.028. Epub 2018 Sep 5.
4
Hair cell protection from aminoglycoside ototoxicity by adenovirus-mediated overexpression of glial cell line-derived neurotrophic factor.通过腺病毒介导的胶质细胞源性神经营养因子过表达保护毛细胞免受氨基糖苷类耳毒性影响。
Hum Gene Ther. 1999 Mar 20;10(5):813-23. doi: 10.1089/10430349950018562.
5
Hearing and hair cells are protected by adenoviral gene therapy with TGF-beta1 and GDNF.通过转化生长因子β1(TGF-beta1)和胶质细胞源性神经营养因子(GDNF)的腺病毒基因疗法可保护听力和毛细胞。
Mol Ther. 2003 Apr;7(4):484-92. doi: 10.1016/s1525-0016(03)00058-3.
6
Cochlear function and transgene expression in the guinea pig cochlea, using adenovirus- and adeno-associated virus-directed gene transfer.使用腺病毒和腺相关病毒介导的基因转移,研究豚鼠耳蜗的耳蜗功能和转基因表达。
Hum Gene Ther. 2001 May 1;12(7):773-81. doi: 10.1089/104303401750148702.
7
[Regulation of AAV-mediated glial cell-line derived neurotrophic factor expression by using improved Tet-on trans-activator].[利用改进的Tet-on反式激活因子调控腺相关病毒介导的胶质细胞源性神经营养因子表达]
Zhonghua Yi Xue Za Zhi. 2005 Feb 16;85(6):405-8.
8
Adeno-associated virus-mediated Bcl-xL prevents aminoglycoside-induced hearing loss in mice.腺相关病毒介导的Bcl-xL可预防小鼠氨基糖苷类药物诱导的听力损失。
Chin Med J (Engl). 2007 Jul 20;120(14):1236-40.
9
Specific and efficient transduction of Cochlear inner hair cells with recombinant adeno-associated virus type 3 vector.用重组3型腺相关病毒载体特异性高效转导耳蜗内毛细胞
Mol Ther. 2005 Oct;12(4):725-33. doi: 10.1016/j.ymthe.2005.03.021.
10
AAV-Mediated Neurotrophin Gene Therapy Promotes Improved Survival of Cochlear Spiral Ganglion Neurons in Neonatally Deafened Cats: Comparison of AAV2-hBDNF and AAV5-hGDNF.AAV 介导的神经营养因子基因治疗促进新生聋猫耳蜗螺旋神经节神经元存活的改善:AAV2-hBDNF 和 AAV5-hGDNF 的比较。
J Assoc Res Otolaryngol. 2019 Aug;20(4):341-361. doi: 10.1007/s10162-019-00723-5. Epub 2019 Jun 20.

引用本文的文献

1
Advancing precision ear medicine: leveraging animal models for disease insights and therapeutic innovations.推进精准耳医学:利用动物模型获取疾病见解和实现治疗创新。
Mamm Genome. 2025 Apr 22. doi: 10.1007/s00335-025-10126-y.
2
Advancements and future prospects of adeno-associated virus-mediated gene therapy for sensorineural hearing loss.腺相关病毒介导的感音神经性听力损失基因治疗的进展与未来前景
Front Neurosci. 2024 Jan 24;18:1272786. doi: 10.3389/fnins.2024.1272786. eCollection 2024.
3
Current Advances in Adeno-Associated Virus-Mediated Gene Therapy to Prevent Acquired Hearing Loss.
腺相关病毒介导的基因治疗在预防获得性听力损失中的最新进展。
J Assoc Res Otolaryngol. 2022 Oct;23(5):569-578. doi: 10.1007/s10162-022-00866-y. Epub 2022 Aug 24.
4
Mechanism and Prevention of Spiral Ganglion Neuron Degeneration in the Cochlea.耳蜗螺旋神经节神经元退变的机制与预防
Front Cell Neurosci. 2022 Jan 5;15:814891. doi: 10.3389/fncel.2021.814891. eCollection 2021.
5
Gene Therapy to the Retina and the Cochlea.视网膜和耳蜗的基因治疗。
Front Neurosci. 2021 Mar 17;15:652215. doi: 10.3389/fnins.2021.652215. eCollection 2021.
6
Research Progress of Hair Cell Protection Mechanism.毛细胞保护机制的研究进展。
Neural Plast. 2020 Oct 9;2020:8850447. doi: 10.1155/2020/8850447. eCollection 2020.
7
Relationships between Intrascalar Tissue, Neuron Survival, and Cochlear Implant Function.内毛细胞组织、神经元存活与人工耳蜗功能的关系。
J Assoc Res Otolaryngol. 2020 Aug;21(4):337-352. doi: 10.1007/s10162-020-00761-4. Epub 2020 Jul 20.
8
GDNF, A Neuron-Derived Factor Upregulated in Glial Cells during Disease.胶质细胞源性神经营养因子,一种在疾病期间于胶质细胞中上调的神经元衍生因子。
J Clin Med. 2020 Feb 7;9(2):456. doi: 10.3390/jcm9020456.
9
Potential of Gene and Cell Therapy for Inner Ear Hair Cells.基因和细胞疗法治疗内耳毛细胞的潜力。
Biomed Res Int. 2018 Jun 13;2018:8137614. doi: 10.1155/2018/8137614. eCollection 2018.
10
Hepatocyte growth factor mimetic protects lateral line hair cells from aminoglycoside exposure.肝细胞生长因子模拟物可保护侧线毛细胞免受氨基糖苷类药物暴露的影响。
Front Cell Neurosci. 2015 Jan 28;9:3. doi: 10.3389/fncel.2015.00003. eCollection 2015.